Elvira Salarda
Family Medicine · Sparta, ILNPI 1114984283
Payments from drug & device makers
Across 140 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$640
- AbbVie$284
- AstraZeneca$276
- Amgen$203
- Boehringer Ingelheim$196
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$120
- plus $619 from 17 others
What the payments were for
- Food & beverage$2,30899%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 33 | $640 |
| AbbVie(2 entities) | 22 | $284 |
| AstraZeneca | 17 | $276 |
| Amgen | 13 | $203 |
| Boehringer Ingelheim | 12 | $196 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $120 |
| Novo Nordisk | 7 | $105 |
| Biohaven Pharmaceuticals, Inc. | 2 | $76 |
| Bayer | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $46 |
| Dexcom, Inc. | 2 | $43 |
| Pfizer | 3 | $43 |
| Mylan Specialty L.p. | 2 | $35 |
| Biosense Webster, Inc. | 1 | $27 |
| Sanofi Pasteur Inc. | 1 | $27 |
| Novartis | 2 | $23 |
| CSL Behring | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| GSK | 1 | $14 |
| Electromed, Inc. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $9 |
How this compares
$2,338 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 61 | $64,925 |
| JanuviaSitagliptin Phosphate | 48 | $53,388 |
| JardianceEmpagliflozin | 49 | $48,211 |
| OzempicSemaglutide | 19 | $18,371 |
| EliquisApixaban | 23 | $17,828 |
| Incruse ElliptaUmeclidinium Bromide | 37 | $12,914 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $11,926 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $11,199 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 22 | $10,536 |
| Spiriva RespimatTiotropium Bromide | 16 | $9,260 |
| NamzaricMemantine Hcl/Donepezil Hcl | 11 | $6,950 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,679 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $3,344 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 85 | $2,352 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $2,236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $196 | $68,00887 claims |
| Lilly USA, LLCMounjaro | $640 | $64,92561 claims |
| GSKIncruse Ellipta, Trelegy Ellipta | $14 | $24,11349 claims |
| Novo NordiskOzempic | $105 | $18,37119 claims |
| PfizerEliquis | $43 | $17,82823 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $276 | $15,60632 claims |
| AbbVieNamzaric | $284 | $6,95011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Sparta
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.